Navigation Links
Premier Biomedical Successfully Advances Cancer Research
Date:12/5/2012

ST. PETERSBURG, Fla., Dec. 5, 2012 /PRNewswire/ -- Premier Biomedical, Inc. (OTC-BB: BIEI) today announced successful advances in its cancer-focused research.  Researchers successfully killed a cancer tumor in a test tube by simply removing crucial molecular compounds necessary for the cancer's development.  This was accomplished utilizing the Felder Doctrine™: "Physically remove the pathophysiologic basis of the disease." 

Dr. Mitchell S. Felder, Chairman of Premier Biomedical, Inc.'s Scientific Advisory Board, stated: "At best, conventional methods, such as chemotherapy and many current marketed cancer-fighting drugs, can target only one single antigen, thus allowing another antigen to survive the treatment and enabling the cancer to progress.  Plus, these blockers or inhibitors often come with dangerous side effects to the patient.  Premier Biomedical aims for far greater efficacy through mixing and matching multiple cancer target antigens simultaneously.  We actually remove the pathophysiologic basis of the disease – targeting the exact cause of the disease and eliminating it – without dangerous side effects."

Specifically, the researchers removed a specified cancer-related Interleukin from a heterogeneous mixture at a picogram (trillionth of a gram) level of accuracy.  This may open the door to a methodology for eradicating cancer tissue without the use of any other medications and/or procedures that are often accompanied by related side effects.  Further testing has resulted in the successful removal of additional critical cancer-related antigens which are important in the development, growth, and metastasis of cancer tissue.  Leukemia and lymphoma cancers were the focus of these recent successes.

About Premier Biomedical, Inc.

Premier Biomedical, Inc
'/>"/>

SOURCE Premier Biomedical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ekahau - A Preferred Provider of Real-Time Location Solutions - Is Awarded an Agreement with the Premier Healthcare Alliance
2. Premier Research Expands Salt Lake City and Phoenix Testing Facilities Adding 50% Capacity
3. Premier Wen Visits Asymchems Tianjin Facility
4. Speech and Language Therapy Jobs and Biomedical Science Jobs - Medicspro Leading the way for Medical Recruitment Agencies in the UK
5. Arecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
6. Creabilis Receives Prestigious Technology Strategy Board Biomedical Catalyst Award
7. The Spring 2012 MediSend Biomedical Repair Training Program™ Sends Graduating Biomedical Technicians to Hospitals Around the World
8. Dr. Victor Ambros and Dr. Gary Ruvkun Win 2012 Dr. Paul Janssen Award for Biomedical Research for Discovery of MicroRNAs
9. QuantRx® Biomedical Provides Corporate Update: Focused on Diagnostics and Feminine Hygiene Segments
10. Bunker Hill Community College Holds Biomedical Careers Graduation Ceremony
11. Fluke Biomedical training center goes global: adds multi-language support
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... Clinovo Staffing Solutions will ... held in Orlando, FL on May 17-20th, 2015. ... Leslie Kolman, Manager of Staffing Solutions, will present Clinovo’s ... Booth #17. , “We are excited to be ... Says Trisha Heredia, Senior Director of Staffing Solutions at ...
(Date:4/29/2015)... USA (PRWEB) April 29, 2015 ... sensing, and imaging on the East Coast, reaffirmed its ... managers, researchers, applications developers, and industry suppliers to meet ... imaging for multiple applications. , The event included 55 ... commercial and scientific sensing and imaging -- and an ...
(Date:4/29/2015)... 2015 Cambrex Corporation (NYSE: CBM ) announced ... Friday, May 1, 2015 before the market opens. , ... host a conference call to discuss the financial results. First ... , Friday, May 1, 2015 at 8:30 a.m. Eastern ... U.S.1-719-325-2454 for International  Passcode:  7993632 Dial-in Replay: ...
(Date:4/29/2015)... Gene therapy can clip out genetic material linked to ... human cardiac cells, according to a study led by researchers ... at Mount Sinai. The study is published in the April ... small random, changes in the genetic code making up genes, ... patients with heart failure,” says Roger J. Hajjar, MD, Director ...
Breaking Biology Technology:Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 2Clinovo Exhibits at the 2015 PharmaSUG Annual Conference on May 17-20th in Orlando, FL 3SPIE DSS provides venue for collaboration vital to research, applications advances 2SPIE DSS provides venue for collaboration vital to research, applications advances 3SPIE DSS provides venue for collaboration vital to research, applications advances 4Gene Therapy Clips Out Heart Failure Causing Gene Mutations 2Gene Therapy Clips Out Heart Failure Causing Gene Mutations 3Gene Therapy Clips Out Heart Failure Causing Gene Mutations 4
... (Nasdaq:,CEPH) today announced that the U.S. Food and ... Drug Application (sNDA) for,FENTORA(R) (fentanyl buccal tablet) [C-II] ... with chronic pain. In,addition, the FDA notified the ... on May 6, 2008, to consider this application., ...
... AMDL, Inc. (Amex:,ADL), headquartered in Tustin, ... China, through its wholly owned subsidiary Jade,Pharmaceutical ... together,with Jade, engages in the development, manufacture ... diagnostic products. It today,announced that more than ...
... Jan. 25 ImaRx Therapeutics,Inc. (Nasdaq: IMRX ... Administration,(FDA) has approved the company,s most current lot ... first lot to be released with extended,expiration dating. ... thrombolytic or clot-dissolving agent indicated,for the treatment of ...
Cached Biology Technology:Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 2Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application 3AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000 2ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating 2ImaRx Therapeutics Receives Urokinase Lot Release Approval With Extended Expiration Dating 3
(Date:4/13/2015)... 2015  higi, a leading cloud-based consumer engagement platform ... engage with their communities around health and wellness, announced ... secure API.  ... affordable, and convenient vehicle to receive validated health information ... The API will allow higi,s trusted partners, on ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Mass. Researchers at the University of Massachusetts Medical School ... is implicated in 20 percent of inherited cases of amyotrophic ... part in sporadic forms of the disease. Discovery of this ... of Nature Neuroscience . While the SOD1 gene ...
... American Academy of Ophthalmology (AAO) - Middle East-Africa ... report on beta carotene,s ability to improve ... The AAO-MEACO meetingthe world,s largest, most comprehensive ophthalmic ... at McCormick Place, Chicago. 9-cis Beta-Carotene Mat ...
... often compared to a book. However, it is not so much ... like a cookbook. The cell reads only those recipes which are ... ,reading, in the book of the cell means creating RNA copies ... The cell uses highly complex, sophisticated regulatory mechanisms to make ...
Cached Biology News:UMMS researchers identify protein associated with sporadic ALS 2UMMS researchers identify protein associated with sporadic ALS 3A mystery solved: How genes are selectively silenced 2
Ezrin/Radixin/Moesin Antibody...
Ezrin/Radixin/Moesin Antibody...
ABCA1 Immunogen: Mouse ABCA1-expressing HeLa stable transfectants. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Goat polyclonal to SART3 ( Abpromise for all tested applications). Antigen: Synthetic peptide: MSNADFAKLFLRK, corresponding to C terminal amino acids 951-963 of Human SART3 Entrez Gene ID: 9...
Biology Products: